Skip to main content

Table 4 BOOM trial study drug dosage table

From: Protocol for a double-blind, randomized controlled trial on the dose-related efficacy of omalizumab in multi-food oral immunotherapy

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us